Luis Malpica Castillo, MD

Peer-Reviewed Articles

1. Wu SY, Fang PQ, Fetooh A, Manzar GS, Corrigan KL, Schrank BR, Nasr L, Chihara D, Malpica Castillo LE, Nair R, Steiner RE, JainP, S Neelapu, Strati P, Nastoupil LJ, Dabaja BS, Pinnix CC, Gunther JR. Ultra low-dose radiation for extranodal marginal zone lymphoma of the lung. Advances in Radiation Oncology None(None):101648, 2024. PMID: None.
2. Candelaria M, Cerrato-Izaguirre D, Gutierrez O, Diaz-Chavez J, Aviles A, Duenas-Gonzalez A, Malpica L. Characterizing the Mutational Landscape of Diffuse Large B-Cell Lymphoma in a Prospective Cohort of Mexican Patients. Int J Mol Sci 25(17):None, 2024. PMID: 39273276.
3. Myers CS, Williams E, Cornejo CB, Pongas G, Toomey NL, Sanches JA, Battistella M, Mo S, Pulitzer M, Moskaluk CA, Bhagat G, Ofori K, Davick JJ, Servitje O, Miyashiro D, Climent F, Ringbloom K, Duenas D, Law C, Zambrano SC, Malpica L, Beltran BE, Castro D, Barreto L, Brites C, Chapman JR, Choi J, Gru AA, Ramos JC. Distinctive genomic features of human T-lymphotropic virus type 1-related adult T-cell leukemia-lymphoma in Western populations. Haematologica None(None):None, 2024. PMID: 39113648.
4. Gunther, J, Xu, J, Bhutani, M, Strati, P, Fang, PQ, Wu, SY, Dabaja, BS, Dong, W, Bhosale, PR, Flowers, CR, Nair, R, Malpica Castillo, LE, Fayad, LE, Iyer, S, Parmer, S, Wang, ML, Lee, HJ, Samaniego, F, Westin, JR, Ahmed, S, Nze, CC, Jain, P, Neelapu, SS, Rodriguez, MA, Chihara, D, Nastoupil, L, Pinnix, CC. Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma. The Lancet Haematology 11(7):e521-e529, 2024. PMID: 38843856.
5. Song, Malpica Castillo, Cai, Zhao, Zhou, Wu, Zhang, Mehta-Shah, Ding, Liu, Li, Zhang, Zheng, Jin, Yang, Shuang, Hyun Yoon, Gao, Li, Zhai, Zou, Xi, Koh, Li, Prince, Zhou, Lin, Liu, Allen, Roncolato, Yang, Kim, Zhu. Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study. The Lancet. Oncology 25(1):117-125, 2023. e-Pub 2024. PMID: 38092009.
6. Castro-Uriol, D, Rios, L, Enriquez-Vera, D, Montoya, J, Runciman, T, Alarcón, S, Zapata, A, Hernández, E, León, E, Malpica Castillo, LE, Valcarcel, B. Real-World Outcomes of Adolescents and Young Adults with Diffuse Large B-Cell Lymphoma. Journal of adolescent and young adult oncology 13(2):323-330, 2023. PMID: 37843922.
7. Candelaria M, Villela L, Torres-Viera MA, Pena C, Roa M, Zambrano D, Colunga-Pedraza PRR, Robles-Rodriguez A, Perez-Jacobo F, Oliver AC, Irigoin MV, Baena R, Idrobo H, Paredes SR, Oliday R, Castro D, Montano-Figueroa E, Perini GF, Fernandez-Aguila JD, Malpica LE, Beltran BE, Castillo JJ. Real-world experience in older patients with diffuse large B-cell lymphoma treated in Latin America: A study by the Latin American study group of lymphoproliferative disorders (GELL). J Geriatr Oncol 14(7):101565, 2023. PMID: 37419788.
8. Castro D, Valcarcel B, Runciman T, Huerta-Collado Y, Paredes S, Beltran BE, Castillo JJ, Malpica L. The prognostic role of red cell distribution width on all-cause and cause-specific outcomes in peripheral T-cell lymphoma: a retrospective cohort study. Leuk Lymphoma None(None):1-9, 2023. e-Pub 2023. PMID: 37132428.
9. Qiu L, Tang G, Li S, Vega F, Lin P, Wang SA, Wang W, Iyer SP, Malpica L, Miranda RN, Konoplev S, Tang Z, Fang H, Medeiros LJ, Xu J. DUSP22 rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma. Haematologica 108(6):1604-1615, 2023. e-Pub 2023. PMID: 36453104.
10. 20Aguilar C, Beltran B E, Morales D, Gutiérrez-Garibay M, Villela L, Marques-Piubelli M L, Vega F, Miranda R N, Malpica LE. Isolated cardiac valve involvement in smoldering adult T-cell leukemia/lymphoma. Cardiovascular Pathology. Cardiovascular Pathology 64(107513):None, 2023. e-Pub 2022. PMID: 36567046.
11. Valcarcel B, Enriquez-Vera D, De-la-Cruz-Ku G, Chambergo-Michilot D, Calderón-Huaycochea H, Malpica L. Epidemiological Features and Outcomes of HTLV-1 Carriers Diagnosed With Cancer: A Retrospective Cohort Study in an Endemic Country. JCO Glob Oncol 9(None):e2200369, 2023. PMID: 36921240.
12. Riva E, Duarte PJ, Valcárcel B, Remaggi G, Murrieta I, Corzo A, Del Carpio D, Peña C, Vásquez J, Bove V, Teixeira L, Fleury-Perini G, Yantorno S, Samánez C, Lopresti S, Altamirano M, Villela L, Ruiz-Arguelles GJ, Ruiz-Delgado GJ, Montaño E, Verri V, Zamora Pérez E, Pérez Jacobo F, Idrobo H, Martínez-Cordero H, Beltran BE, Ramírez J, Castillo JJ, Malpica Castillo LE. Treatment and Survival Outcomes of Waldenstrom Macroglobulinemia in Latin American Patients: A Multinational Retrospective Cohort Study. JCO Glob Oncol 8(None):e2100380, 2022. PMID: 35939775.
13. Bove V, Riva E, Vásquez J, Peña C, Seehaus C, Samanez C, Bustos J, Hernández M, Fernández J, Ríos O, Rodríguez Y, Figueredo I, Fantl D, Malpica L. Epidemiology and Risk Factors for the Development of Infectious Complications in Newly Diagnosed Multiple Myeloma: A Multicenter Prospective Cohort Study in Latin America. JCO Glob Oncol 8(None):e2200068, 2022. PMID: 35867949.
14. Valcarcel B, Ampuero GS, de la Cruz-Ku G, Enriquez DJ, Malpica L. Outcomes of HTLV-1 Carriers with Diffuse Large B-Cell Lymphoma: A Single-Center Retrospective Matched Cohort Study. Clin Lymphoma Myeloma Leuk 22(4):251-259, 2022. e-Pub 2021. PMID: 34690089.
15. Malpica L, Castro D, Enriquez DJ, Oviedo-Pecho R, Peña C, Idrobo H, Fiad L, Prates M, Valcarcel B, Paredes A, Sánchez G, Castillo JJ, Moisés C, Villela L, Ramos JC, Biglione M, Beltran BE, Linfoproliferativos (GELL) GDELD. An international, multicenter, retrospective study on the positive impact of cutaneous involvement on the clinical outcome of adult T-cell leukemia/lymphoma. Leuk Lymphoma 63(2):315-325, 2022. e-Pub 2021. PMID: 34585997.
16. Castillo JJ, Beltran BE, Malpica L, Marques-Piubelli ML, Miranda RN. Anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK?+?LBCL): a systematic review of clinicopathological features and management. Leuk Lymphoma 62(12):2845-2853, 2021. e-Pub 2021. PMID: 34151703.
17. Medeiros LJ, Marques-Piubelli ML, Sangiorgio VFI, Ruiz-Cordero R, Vega F, Feldman AL, Chapman JR, Clemens MW, Hunt KK, Evans MG, Khoo C, Lade S, Silberman M, Morkowski J, Pina EM, Mills DC, Bates CM, Magno WB, Sohani AR, Sieling BA, O'Donoghue JM, Bacon CM, Patani N, Televantou D, Turner SD, Johnson L, MacNeill F, Wotherspoon AC, Iyer SP, Malpica LE, Patel KP, Xu J, Miranda RN. Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship. Mod Pathol 34(12):2154-2167, 2021. e-Pub 2021. PMID: 34226673.
18. Wu SY, Fang P, Huen AO, Iyer SP, Nair R, Steiner R, Luis Malpica Castillo, Duvic M, Fayad L, Ahmed S, Jain P, Neelapu SS, Strati P, Westin J, Nastoupil L, Pinnix CC, Dabaja B, Gunther JR. Concurrent Radiation Therapy With the Antibody-Drug Conjugates Brentuximab Vedotin and Polatuzumab Vedotin. Int J Radiat Oncol Biol Phys 111(3S):e301, 2021. PMID: 34701130.
19. Malpica L, Enriquez DJ, Castro DA, Peña C, Idrobo H, Fiad L, Prates M, Otero V, Biglione M, Altamirano M, Sandival-Ampuero G, Aviles-Perez U, Meza K, Aguirre-Martinez L, Cristaldo N, Maradei JL, Guanchiale L, Soto P, Viñuela JL, Cabrera ME, Paredes SR, Riva E, Di Stefano M, Noboa A, Choque JA, Candelaria M, Von Glasenapp A, Valvert F, Torres-Viera MA, Castillo JJ, Ramos JC, Villela L, Beltran BE. Real-World Data on Adult T-Cell Leukemia/Lymphoma in Latin America: A Study From the Grupo de Estudio Latinoamericano de Linfoproliferativos. JCO Glob Oncol 7:1151-1166, 2021. PMID: 34270330.
20. Malpica L. Paving the path to better understanding T-cell lymphomas: The importance of lymphoma registries. Lancet Reg Health West Pac 10:100134, 2021. e-Pub 2021. PMID: 34327347.
21. Valcarcel B, De-la-Cruz-Ku G, Malpica L, Enriquez-Vera D. Clinical features and outcome of Aeromonas sobria bacteremia in pediatric and adult patients with hematologic malignancies: A single-center retrospective study in Peru. PLoS One 16(8):e0255910, 2021. e-Pub 2021. PMID: 34379680.
22. Malpica L, Moll S. Practical approach to monitoring and prevention of infectious complications associated with systemic corticosteroids, antimetabolites, cyclosporine, and cyclophosphamide in nonmalignant hematologic diseases. Hematology Am Soc Hematol Educ Program 2020(1):319-327, 2020. PMID: 33275674.
23. Beltrán BE, Villela L, Torres MA, Otero V, Fiad L, Peña C, Cabrera ME, León P, Idrobo H, Castro DA, Paredes S, Perdomo I, Abello V, Rojas C, Ramirez-Ibargüen A, Candelaria M, Pérez-Jacobo F, Montaño-Figueroa E, Best C, Goméz-De Leon A, Gómez-Almaguer D, Ruiz-Argüelles G, Hernández-Hernández J, Malpica L, Castillo JJ, Sotomayor EM, Linfoproliferativos [GELL]) LAGOLD(DELD. A Multi-Institutional Validation of the Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients With Diffuse Large B-Cell Lymphoma: A Study From The Latin American Group of Lymphoproliferative Disorders (GELL). Clin Lymphoma Myeloma Leuk 20(10):637-646, 2020. e-Pub 2020. PMID: 32513598.
24. Malpica L, Mufuka B, Galeotti J, Tan X, Grover N, Clark SM, Beaven A, Muss H, Dittus C. A retrospective study on prephase therapy prior to definitive multiagent chemotherapy in aggressive lymphomas. Leuk Lymphoma 61(6):1508-1511, 2020. e-Pub 2020. PMID: 32037934.
25. Nichols, MM, Malpica Castillo, LE, Muss, H, Montgomery, ND. “Circulating lobular breast carcinoma masquerading as acute leukemia”. Human Pathology: Case Reports 16, 2019. PMID: None.
26. Malpica L, Pimentel A, Reis IM, Gotuzzo E, Lekakis L, Komanduri K, Harrington T, Barber GN, Ramos JC. Epidemiology, clinical features, and outcome of HTLV-1-related ATLL in an area of prevalence in the United States. Blood Adv 2(6):607-620, 2018. PMID: 29545256.
27. Malpica LE, Campuzano-Zuluaga G, Toomey N, Pimentel A, Alenca AJ, Chapman-Fredricks JR, CarlosRamos J. Targeting CD30 Expression in Adult T-Cell Leukemia-Lymphoma (ATLL). Blood 130(1):374, 2017. PMID: None.
28. Luis M, Mariano L, Sofia Z, Clinton W, Jr, Martin M, Eleazar AM, Eduardo G. P-219 HTLV-1 Infected Regulatory T-Cell Expansion in Duodenum is Highly Associated with a Complicated Clinical Course in HTLV-1/Strongyloides Co-Infection. None 20(1):S113–S114, 2014. PMID: None.

Invited Articles

1. Ospina A, Idrobo H, Malpica L. Consensus of the Latin American Study Group of Lymphoproliferative Disorders (GELL) for the management of Lymphomas in a state of pandemic SARS CoV-2 COVID 19. None None(None):None, 2020. PMID: None.
2. Malpica LE. The Who, What, and When of Immunizations. Blood None(None):None, 2020. PMID: None.
3. Malpica LE. Putting the Brakes on Dismal Outcomes for Virus-Driven ATLL. None None(None):None, 2020. PMID: None.
4. Malpica LE. Many patients with blood disorders don’t receive recommended vaccines and screenings. None None(None):None, 2019. PMID: None.
5. Guerra H, Malpica L, Seas C. The Institute of Tropical Medicine ‘Alexander Von Humboldt’: Past, Present and Future Projections. None, 2013. PMID: None.
6. Guerra, Humberto, Malpica, Ramos, Rafael. The Institute of Tropical Medicine 'Alexander Von Humboldt': Past, Present and Future Projections. Heredian act None(53):13-28, 2013. PMID: None.

Other Articles

1. Ramirez-Gamero A, Martinez-Cordero H, Beltran BE, Florindez J, Malpica L, Castillo JJ Plasmablastic lymphoma: 2024 update on diagnosis, risk stratification, and management. Am J Hematol 99(8):1586-1594, 2024. PMID: 38767403.
2. Malpica L, Marques-Piubelli ML, Beltran BE, Chavez JC, Miranda RN, Castillo JJ EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2024 update on the diagnosis, risk-stratification, and management. Am J Hematol 99(10):2002-2015, 2024. PMID: 38957951.
3. Lionel AC, Gurumurthi A, Fetooh A, Eldaya R, Ahmed S, Iyer SP, Nastoupil LJ, Westin J, Nair R, Fayad L, Malpica L, Tummala S, Flowers C, Neelapu SS, Wang ML, Jain P Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement. Leuk Lymphoma 65(5):669-673, 2024. PMID: 38248629.
4. Medeiros LJ, Marques-Piubelli ML, Sangiorgio VFI, Ruiz-Cordero R, Vega F, Feldman AL, Chapman JR, Clemens MW, Hunt KK, Evans MG, Khoo C, Lade S, Silberman M, Morkowski J, Pina EM, Mills DC, Bates CM, Magno WB, Sohani AR, Sieling BA, O'Donoghue JM, Bacon CM, Patani N, Televantou D, Turner SD, Johnson L, MacNeill F, Wotherspoon AC, Iyer SP, Malpica LE, Patel KP, Xu J, Miranda RN Corrigendum to "Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship." [Modern Pathology 34 (2021) 2154-2167]. Mod Pathol 36(12):100355, 2023. PMID: 37948938.
5. Wu, Fang, Wang, Ahmed, Duvic, Jain, Malpica Castillo, Nair, Steiner, Strati, Huen, Iyer, Pinnix, Dabaja, Gunther Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of Lymphoma. Adv Radiat Oncol 8(6):None, 2023. PMID: 37448588.
6. Malpica L, Marques-Piubelli ML, Beltran BE, Chavez JC, Miranda RN, Castillo JJ EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2022 update on diagnosis, risk-stratification, and management. Am J Hematol 97(7):951-965, 2022. PMID: 35472248.
7. Valcarcel B, Castro D, Enriquez DJ, Peña C, Idrobo H, Fiad L, Prates M, Paredes SR, Torres Viera MA, Perini GF, Castillo JJ, Villela L, Beltran BE, Ramos JC, Malpica-Castillo L A Simplified Novel Prognostic Score to Predict Early Mortality and Disease Progression in Patients with Aggressive Adult T-Cell Leukemia/Lymphoma. Blood 138(1):1404, 2021. PMID: None.
8. Idrobo H, Castro D, Fiad L, Huerta- Collado YM, Otero V, Paredes SR, Garcia-Robledo JE, Lasso JF, Martinez-Cordero H, Osorio-Gomez AM, Sanchez-Perea JA, Valcarcel B, Villela L, Torres Viera MA, Beltran BE, Castillo JJ, Malpica-Castillo L Clinico-Epidemiological Features of Elderly Patients with Peripheral T-Cell Lymphoma Not Otherwise Specified: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL). None 138(1):2468, 2021. PMID: None.
9. Malpica Castillo LE, Enriquez DJ, Castro DA, Peña C, Idrobo H, Fiad L, MD, Prates M, Otero V, Churin M, Altamirano M, Sandival-Ampuero G, Aviles-Perez U, Meza K, Aguirre-Martinez L, Nancy C, Maradei JL, Guanchiale L, Soto P, Viñuela JL, Cabrera ME, Paredes SR, Riva E, Stefano MD, Noboa A, Choque JA, Candelaria M, Glasenapp AV, Valvert F, Viera MT, Perini GF, Sotomayor E, Castillo JJ, Ramos JC, Villela LV, Beltrán BE Epidemiology, Clinical Features, and Outcome of HTLV-1-Related Adult T-Cell Leukemia/Lymphoma in Latin America: A Study from the Latin American Group of Lymphoproliferative Disorders (GELL). Blood 136(1):18-21, 2020. PMID: None.
10. Aleixo GFP, Shachar SS, Nyrop KA, Muss HB, Malpica L, Williams GR Myosteatosis and prognosis in cancer: Systematic review and meta-analysis. Crit Rev Oncol Hematol 145(None):102839, 2020. PMID: 31877534.
11. Malpica L, van Duin D, Moll S Preventing infectious complications when treating non-malignant immune-mediated hematologic disorders. Am J Hematol 94(12):1396-1412, 2019. PMID: 31571266.
12. Malpica Castillo LE, Campuzano-Zuluaga G, Toomey NL, Pimentel A, Chapman-Fredricks JR, Ramos JC Impact of IRF4/MUM1 Expression on Adult T-Cell Leukemia/Lymphoma and Treatment Outcome. Blood 130(1):4134, 2017. PMID: None.

Editorials

1. Malpica Castillo, Moll. New Herpes Zoster Vaccine: What the Hematologist Needs to Know. The Hematologist 4(15):None, 2018. PMID: None.

Abstracts

1. Candelaria M, Villela L, Torres Viera MA, Peña C, Roa M, Zambrano D, Colunga-Pedraza PR, Robles-Rodriguez A, Pérez-Jacobo F, Oliver AC, Irigoín MV, Baena R, Idrobo H, Paredes SR, Oliday R, Castro D, Figueroa EM, Perini GF, Malpica Castillo LE, Beltran BE, Castillo JJ. Diffuse large B cell lymphoma in the Elderly: Real World Experience in Latin America. A Study from the Grupo de Estudio Latinoamericano de Linfoproliferativos (GELL). Blood 140(1):6697-6698, 2023. PMID: None.
2. Elias A, Marques-Piubelli ML, Nair R, Prakash R, Ahmed S, Malpica L, Lee HJ, Xu J, Flowers CR, Neelapu SS, Vega F, Miranda R, Iyer SP. Prognostic Significance of CD30 Expression and Response to Brentuximab Vedotin in Patients with Angioimmunoblastic T Cell Lymphoma. Blood 142(1):1714, 2023. PMID: None.
3. Gunther J, Xu J, Bhutani MS, Strati P, Fang P, Wu S, Dabaja BS, Dong W, Bhosale P, Flowers CR, Nair R, Malpica L, Jain P, Neelapu SS, Rodriguez MA, Chihara D, Nastoupil LJ, Pinnix CC. Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Gastric MALT Lymphoma. Blood 142(1):298, 2023. PMID: None.
4. Rivarola SG, Stemmelin GR, Vasquez JF, Enciso Arrua ME, Glasenapp SV, Oliver C, Warley F, Orlova M, Rios Jiménez RO, Quiroz AR, Viera MT, Quintero HI, Garces Paz DF, Castro D, Fernández Águila JD, Irigoín V, Castillo JJ, Beltran BE, Vilela L, Valcarcel B, Malpica Castillo LE. Clinical Features, Treatment Patterns and Outcomes of 864 Newly Diagnosed Hodgkin Lymphoma Patients in Latin America and the Impact of PET Scan Availability on Survival: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL). Blood 142(1):4441, 2023. PMID: None.
5. Ruan J, Chen Z, Larson MC, Bennani N, Wallace D, Allen PB, Jaye DL, Cohen JB, Malpica Castillo LE, Vega F, Inghirami G, Mou E, Casulo C, Mehta-Shah N, Martin P, Maurer MJ, Kahl BS, Lossos IS, Cerhan JR, Flowers CR, Feldman AL. Patterns of Care and Impact of Initial Treatment in Peripheral T-Cell Lymphoma: Outcome Analysis from the Lymphoma Epidemiology of Outcomes (LEO) and Molecular Epidemiology Resource (MER) Prospective Cohort Study. Blood 142(1):3079, 2023. PMID: None.
6. Villela Martinez LM, Beltran BE, Candelaria M, Viera MT, Ramirez AF, Quintero HI, Oliver C, Perini GF, Montano Figueroa EH, Korin L, Fiad L, Stemmelin GR, Perez-Jacobo F, Castro D, Paredes SR, Irigoín V, Colunga-Pedraza PR, Gomez-Almaguer D, Ruiz-Argüelles G, Valvert F, Otañez M, Rodriguez AR, Best C, Hernandez-Hernandez JA, Malpica L, Castillo JJ. Validating the Halp Score (Hemoglobin,Albumin, Lymphocytes, and Platelets) and the Neutrophil/Lymphocyte Ratio (NLR) As Prognostic Factors for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma. Retrospective Analysis By the Grupo De Estudio De Latino America De Linfoproliferativos (GELL). Blood 142(1):1757, 2023. PMID: None.
7. Fischer T, Idrobo H, Pavlovsky A, Castro D, Beltran B, Enriquez DJ, Vasquez JF, Roche C, Artiles D, Valvert F, Villela LM, Pereira J, Oliver C, Tavarez JV, B Brasil SA, Cecyn KZ, Castro N, Baptista R, S Medina SD, Maciel Borducchi DM, Bellesso M, De Farias DLC, Gonzaga YB, Warley F, Fiad L, Korin L, Pereyra PH, Peña C, Torres MA, Mahuad CV, Glasenapp AV, Quiroz AR, Gazitua R, Samanez-Figari CA, Sardu L, Arriola JP, Isnardi S, Maradei JL, Gabus RH, Enrico AI, Guanchiale LA, Arangueren FN, García Altuve JI, Cerutti A, Penalva R, Garcia Trucco JI, Pessolani F, Gilli V, Diaz J, Martinez ME, Jarchum G, Perinotto GC, Barraza T, Ciarlo S, Rojas C, Rios Jiménez RO, Souza CD, Manni M, CM Miranda ECM, Federico M, Valcarcel B, Chiattone C, Malpica Castillo LE. Epidemiology, Clinical Features and Outcomes of Peripheral T-Cell Lymphoma in Latin America. Blood 142(1):186, 2023. PMID: None.
8. Jain P, Chi Young OK, Nastoupil LJ, Westin J, Hill HA, Nair R, Iyer SP, Fetooh A, Lee HJ, Ahmed S, Kanagal-Shamanna R, Jelloul FZ, Malpica Castillo LE, Liu Y, Li Y, Vargas J, Feng L, Badillo M, Thirumurthi S, Xu G, Deswal A, Iliescu C, Nguyen VQ, Tang G, Patel KP, Vega F, Medeiros L, Wang ML, Flowers CR. Acalabrutinib with Rituximab As First-Line Therapy for Older Patients with Mantle Cell Lymphoma – a Phase II Clinical Trial. Blood 142(1):3036, 2023. PMID: None.
9. Villela Martinez LM, Beltran BE, Candelaria M, Viera MT, Ramirez AF, Quintero HI, Oliver C, Perini GF, Montano Figueroa EH, Korin L, Fiad L, Stemmelin GR, Perez-Jacobo F, Castro D, Paredes SR, Irigoín V, Colunga-Pedraza PR, Gomez-Almaguer D, Ruiz-Argüelles G, Valvert F, Otañez M, Rodriguez AR, Best C, Hernandez-Hernandez JA, Malpica L, Castillo JJ. Validating the Systemic Inmmune-Inflamation Index (SII) As a Prognostic Biomarker of Overall Survival in Diffuse Large B-Cell Lymphoma: A Retrospective Analyses By the Gruppo De Estudio Latinoamericano De Linfoproliferativos (GELL). Blood 142(1):1775-1775, 2023. PMID: None.
10. Westin J, Nair R, Fayad L, Iyer SP, Malpica L, Neelapu SS, Samaniego F, Steiner RE, Strati P, Mathew S, Griffith D, Nastoupil LJ, Montinez W, Rodriguez MA, Hagemeister F, Feng L, Vega F, Flowers CR, Ahmed S. Nivolumab and Ibrutinib for Treatment of Patients with Refractory or Relapsed Central Nervous System Lymphoma. Blood 142(1):1721, 2023. PMID: None.
11. Candelaria M, Villela Martinez LM, Beltran BE, Ramirez AF, Viera MT, Oliver C, Quintero HI, perez-Jacobo F, Perini GF, Peña C, Korin L, Castro D, Irigoín V, Paredes SR, Hernandez-Hernandez JA, Colunga-Pedraza PR, Gomez-Almaguer D, Ruiz-Argüelles G, Otañez M, Castillo JJ, Malpica Castillo LE. Real-World Data on the Clinical Features, Therapy Patterns and Outcomes of 651 Elderly Patients with Diffuse Large B-Cell Lymphoma in Latin America: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL). Blood 142(1):1748, 2023. PMID: None.
12. Westin J, Steiner RE, Chihara D, Ahmed S, Jain P, Malpica L, Iyer SP, Fayad L, Nair R, Nastoupil LJ, Neelapu SS, Henderson J, Rodriguez MA, Hagemeister F, Vega F, Pulsifer B, Tom J, Durmic I, Masand G, Feng L, Green MR, Flowers CR, Strati P. Smart Stop: Lenalidomide, Tafasitamab, Rituximab, and Acalabrutinib Alone and with Combination Chemotherapy for the Treatment of Newly Diagnosed Diffuse Large B-Cell Lymphoma. Blood 142(1):856, 2023. PMID: None.
13. Strati P, Feng L, Westin J, Nair R, Fayad L, Rodriguez MA, Chihara D, Malpica L, Henderson J, Gallardo M, Marques-Piubelli ML, Turova P, Zaitsev A, Wang I, Flowers CR, Nastoupil LJ, Neelapu SS. Addition of Acalabrutinib to Lenalidomide and Rituximab Induces High Complete Response Rates in Patients with Previously Untreated Follicular Lymphoma: Results of a Phase II Study. Blood 142(1):983, 2023. PMID: None.
14. Perini GF, Idrobo H, Oliver C, Von Glasenapp SA, Castro D, Villela Martinez LM, Beltran B, Stemmelin GR, Candelaria M, Colunga-Pedraza PR, Diaz J, Korin L, Idarraga JO, Martinez-Cordero H, Chiattone C, Dias MA, Baena R, Paredes SR, Viera MT, Rios Jiménez RO, Valvert F, Warley F, Rivarola SG, Guanchiale LA, Ferrari SR, Pereyra PH, Bogado Colmán JJ, Hernandez M, Abello V, Rodriguez AR, Roa M, Salinas VA, Macias Abasto JM, Spinelli VL, Bellesso M, Malpica Castillo LE, Castillo JJ. Primary CNS Lymphoma in Latin America: A Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL) Survey in 80 Cancer Centers in Latin America. Blood 142(1):2422, 2023. PMID: None.
15. Oliver AC, Villela Martinez LM, Irigoín MV, Cardozo ML, Glasenapp Gossen SAV, Roa Salinas MA, Torres Viera MA, Lema V, Castro D, Alvarez J, Perez-Jacobo F, Robles A, Otañez M, Peña C, Bradvica V, Paredes SR, Perini GF, Idrobo H, Beltran BE, Malpica Castillo LE, Castillo JJ. Evolution of Treatment Patterns and Prognostic Biomarkers in Latin American Patients with Chronic Lymphocytic Leukemia: A Study by the Grupo de Estudio Latinoamericano de Linfoproliferativos (GELL. Blood 140(1):10918-10920, 2022. PMID: None.
16. Villela Martinez LM, Beltrán BE, Torres Viera MA, Idrobo H, Candelaria M, Perini GF, Oliver AC, Castro D, Oliday R, Paredes SR, Ramirez-Ibarguen AF, Andino L, Rivas-Vera S, Glasenapp Gossen SAV, Irigoin V, Agreda GP, Perez-Jacobo F, Colunga-Pedraza PR, Figueroa EM, Fiad L, Valvert F, Peña C, Hernández-Hernández JA, Otero V, Otañez M, Ruiz-Arguelles GJ, Robles A, Best C, Gomez-Almaguer D, Baena R, Urquijo S, Hernandez E, Álvarez JL, Castro M, Castillo JJ, Malpica Castillo LE. Validating the Prognostic Value of Anemia and Thrombocytopenia in Latin American Patients with Diffuse Large B cell Lymphoma: A Study from the Grupo de Estudio Latinoamericano de Linfoproliferativos (GELL). Blood 140(1):6708-6710, 2022. PMID: None.
17. Valcarcel B, Sano H, Katsuya H, Utsunomiya A, Otsuka M, Miyahara M, Takamatsu Y, Ishitsuka K, Kimura S, Suzumiya J, Tamura K, Enriquez DJ, Castro D, Beltran BE, Idrobo H, Peña C, Fiad L, Ramos JC, Malpica Castillo LE. Progression of Disease within 5 Months of Adult T-Cell Leukemia-Lymphoma (ATL5) As a Clinical Endpoint for High-Risk Mortality Outcomes in the Real-World Setting: A Multinational Cohort Analysis. blood 140(1):6664-6665, 2022. PMID: None.
18. Glasenapp Gossen SAV, Martinez-Cordero H, Villela L, Colunga-Pedraza PR, Perez-Jacobo F, Robles A, Diego Fernando Garces PAZ, Idrobo H, Castro D, Paredes SR, Beltran BE, Oliver AC, Irigoin V, Ospina JA, Rios RO, Malpica L. Treatment Patterns and Survival of Patients with Relapsed and Refractory Classical Hodgkin Lymphoma in Latin America. Blood 140(1):9429-9430, 2022. PMID: None.
19. Oliver AC, Villela Martinez LM, Irigoín MV, Cardozo ML, Glasenapp Gossen SAV, Roa Salinas MA, Torres Viera MA, Lema V, Castro D, Alvarez J, Perez-Jacobo F, Robles A, Otañez M, Peña C, Bradvica V, Paredes SR, Perini GF, Idrobo H, Beltran BE, Malpica Castillo LE, Castillo JJ. Evolution of Treatment Patterns and Prognostic Biomarkers in Latin American Patients with Chronic Lymphocytic Leukemia: A Study by the Grupo de Estudio Latinoamericano de Linfoproliferativos (GELL). Blood 140(1):None, 2022. PMID: None.
20. Candelaria M, Villela L, Torres Viera MA, Peña C, Roa M, Zambrano D, Colunga-Pedraza PR, Robles-Rodriguez A, Pérez-Jacobo F, Oliver AC, Irigoín MV, Baena R, Idrobo H, Paredes SR, Oliday R, Castro D, Figueroa EM, Beltran BE, Perini GF, Malpica Castillo LE, Castillo JJ. Diffuse large B cell lymphoma in the Elderly: Real World Experience in Latin America. A Study from the Grupo de Estudio Latinoamericano de Linfoproliferativos (GELL). Blood 140(1):6697–6698, 2022. PMID: None.
21. Valcarcel B, Sano H, Katsuya H, Utsunomiya A, Otsuka M, Miyahara M, Takamatsu Y, Ishitsuka K, Kimura S, Suzumiya J, Tamura K, Enriquez DJ, Castro D, Beltran BE, Idrobo H, Peña C, Fiad L, Ramos JC, Malpica Castillo LE. Progression of Disease within 5 Months of Adult T-Cell Leukemia-Lymphoma (ATL5) As a Clinical Endpoint for High-Risk Mortality Outcomes in the Real-World Setting: A Multinational Cohort Analysis. Blood 140(1):6664–6665, 2022. PMID: None.
22. Valcarcel B, Sano H, Katsuya H, Utsunomiya A, Otsuka M, Miyahara M, Takamatsu Y, Ishitsuka K, Kimura S, Suzumiya J, Tamura K, Enriquez DJ, Castro D, Beltran BE, Idrobo H, Peña C, Fiad L, Ramos JC, Malpica Castillo LE. Clinical Features, Treatment Patterns, and Outcomes Among 837 Patients with Adult T-Cell Leukemia-Lymphoma in the Real-World Setting: A Comparison of Endemic Regions. Bloor 140(1):1072–1073, 2022. PMID: None.
23. Villela Martinez LM, Beltrán BE, Torres Viera MA, Idrobo H, Candelaria M, Perini GF, Oliver AC, Castro D, Oliday R, Paredes SR, Ramirez-Ibarguen AF, Andino L, Rivas-Vera S, Glasenapp Gossen SAV, Irigoin V, Agreda GP, Perez-Jacobo F, Colunga-Pedraza PR, Figueroa EM, Fiad L, Valvert F, Peña C, Hernández-Hernández JA, Otero V, Otañez M, Ruiz-Arguelles GJ, Robles A, Best C, Gomez-Almaguer D, Baena R, Urquijo S, Hernandez E, Álvarez JL, Castro M, Castillo JJ, Malpica Castillo LE. Validating the Prognostic Value of Anemia and Thrombocytopenia in Latin American Patients with Diffuse Large B cell Lymphoma: A Study from the Grupo de Estudio Latinoamericano de Linfoproliferativos (GELL). Blood 140(1):6708–6710, 2022. PMID: None.
24. Zhao J, Chiao EY, Mazul AL, Deshmukh A, Malpica L, Patel TA, Kizub DA. Cancer incidence in U.S. adolescent and young adult (AYA) women stratified by race/ethnicity and region. Journal of Clinical Oncology 40(16):e18529-e18529, 2022. PMID: None.
25. Malpica-Castillo L, Feng L, Xu J, Nair R, Elias A, Jain P, Chihara D, Steiner R, Fayad L, Samaniego F, Ahmed S, Fowler NH, Nastoupil L, Srour SA, Nieto Y, Hosing C, Miranda RN, Vega F, Pinnix CC, Gunther JR, Fang P, Wu S, Dabaja BS, Medeiros J, Wang M, Neelapu SS, Flowers CR, Iyer SP. Long Term Outcome Patterns and Risk Factors for Early Mortality and Disease Progression in ALK-Positive Anaplastic Large Cell Lymphoma. Blood 138(1):2463, 2021. PMID: None.
26. Perini GF, Villela L, Beltran BE, Castro D, Otero V, Kalmus M, Fiad L, Peña C, Idrobo H, Candelaria M, Glasenapp AV, Perdomo I, Feres C, Prates MV, Paredes SR, Perez-Jacobo F, Ramirez-Ibarguen AF, Gajardo C, Roa Salinas MA, Otañez M, Castillo LM. Updated Analysis Confirms Sustained Poor Prognosis of COVID-19 in Patients with Lymphoma in Latin America: A Cohort of 160 Patients from Gell. Blood 138(1):2520, 2021. PMID: None.
27. Beltran BE, Castro D, Villela L, Figueroa EM, Ramirez-Ibarguen AF, Candelaria M, Perini GF, Oliver AC, Martinez-Cordero H, Idrobo H, Rios RO, Valvert F, Paredes SR, Pellegrino CC, Rodriguez Y, Lopez F, Irigoin V, De Galvez MG, Castillo JJ, Valcarcel B, Castillo LM. A Novel Prognostic Index for Patients with EBV-DLBCL NOS: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL). Blood 138(1):1436, 2021. PMID: None.
28. Torres Viera MA, Villela L, Beltran BE, Castro D, Candelaria M, Idrobo H, Otero V, Glasenapp AV, Valvert F, Paredes SR, Barrios J, Ramirez-Ibarguen AF, Peña C, Cabrera ME, Gajardo C, Roa M, Díaz C, Fiad L, Best C, Prates M, Ospina JA, Idárraga LS, Martinez H, Otañez M, Luna MA, Lome C, Pérez-Jacobo F, Baena R, Macias J, Cristaldo N, Perini GF, Cardoso LL, Rios RO, Rodriguez Y, Valcarcel B, Castillo JJ, Castillo LM. Serum Albumin and Neutrophil-to-Lymphocyte Ratio, Two Independent Factor Predicting Survival in Patients with Follicular Lymphoma: A Multi-Institutional Retrospective Cohort of 741 FL, from the Latin American Lymphoproliferative Study Group (GELL). Blood 138(1):4515, 2021. PMID: None.
29. Pinnix CC, Dabaja BS, Gunther JR, Fang P, Wu S, Nastoupil L, Strati P, Nair R, Ahmed S, Steiner RE, Malpica-Castillo L, Chihara D, Jain P, Fayad L, Westin JR, Neelapu SS, Rodriguez MA, Hagemeister FB, Lee HJ, Wang M, Samaniego F, Fowler NH, Flowers CR, Feng L, Chi L, Esmaeli B. Phase II Trial of Response Adapted Ultra Low Dose (ULD) Orbital Radiation Therapy for Indolent B Cell Lymphoma. Blood 138(1):3526, 2021. PMID: None.
30. Nair R, Deen N, Ahmed S, Miranda RN, Fowler NH, Fayad L, Steiner RE, Hagemeister FB, Rodriguez MA, Lee HJ, Strati P, Malpica-Castillo L, Chihara D, Jain P, Gunther JR, Flowers CR, Medeiros L, Nieto Y, Ramdial JL, Neelapu SS, Nastoupil L, Green MR, Wang M, Vega F, Feng L, Iyer SP, Westin JR. Outcome of Patients with T- Cell Histiocyte Rich B Cell Lymphoma: Single Institution Series. Blood 138(1):1448, 2021. PMID: None.
31. Castro D, Beltran BE, Villela L, Figueroa EM, Ramirez-Ibarguen AF, Candelaria M, Perini GF, Oliver AC, Martinez-Cordero H, Idrobo H, Rios RO, Valvert F, Paredes SR, Pellegrino CC, Rodriguez Y, Lopez F, Irigoin V, De Galvez MG, Castillo JJ, Valcarcel B, Castillo LM. Clinicopathological Features and Outcomes of EBV Positive and Negative DLBCL: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL). Blood 138(1):1442, 2021. PMID: None.
32. Villela L, Beltrán BE, Castro D, Ramirez-Ibarguen AF, Torres Viera MA, Perini GF, Lome C, Candelaria M, Idrobo H, Paredes SR, Glasenapp AV, Valvert F, Otero V, Peña C, Fiad L, Best C, Rios RO, Martinez-Cordero H, Otañez M, Pérez-Jacobo F, Idarraga JO, Baena R, Nancy C, Oliver AC, Irigoín MV, Cardoso LL, Rodriguez Y, Macias J, Prates MV, Luna MA, Cabrera ME, Roa M, Gajardo C, Díaz C, Montano Figueroa EH, Bichara E, Bonfil KL, Cordero-Moreno VL, Valcarcel B, Castillo JJ, Castillo LM. Biological and Classical Prognostic Factors with Impact on Overall Survival in Patients with Early Stage (I/II) Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL). Blood 138(1):2516, 2021. PMID: None.
33. Nair R, Feng L, Gunther JR, Xu J, Malpica-Castillo L, Huen A, Cabala CT, Heberton M, Fang P, Ahmed S, Miranda RN, Fayad L, Steiner R, Lee HJ, Chihara D, Jain P, Srour SA, Nieto Y, Nastoupil L, Pinnix CC, Neelapu SS, Flowers CR, Medeiros L, Hosing C, Wang M, Dabaja BS, Vega F, Iyer SP. Outcomes of Patients with Extranodal Natural Killer/T-Cell Lymphoma: Single Institution Series. Blood 138(1):4536, 2021. PMID: None.
34. Paredes SR, Castro D, Runciman T, Huerta- Collado YM, Beltran BE, Zuñiga MA, Castillo JJ, Valcarcel B, Castillo LM. Evaluating the Prognostic Value of Inflammatory Biomarkers and Traditional Prognostic Tools in PTCL: A National, Multicenter Retrospective Study. Blood 138(1):2474, 2021. PMID: None.
35. Wang M, Jain P, Lee HJ, Ok CY, Hill H, Navsaria L, Kanagal-Shamanna R, Malpica-Castillo L, Nair R, Iyer SP, Samaniego F, Chen W, Oriabure O, Feng L, Thirumurthi S, Santos D, Tang G, Vega F, Li S, Avellaneda M, Badillo M, Flowers CR. Ibrutinib Plus Rituximab and Venetoclax (IRV) Followed By Risk-Stratified Observation or Short Course R-Hypercvad/MTX in Young Patients with Previously Untreated Mantle Cell Lymphoma - Phase-II Window-2 Clinical Trial. Blood 138(1):3525, 2021. PMID: None.
36. Perini GF, Villela L, Beltran BE, Castro D, Otero V, Kalmus M, Fiad L, Peña C, Idrobo H, Candelaria M, Glasenapp AV, Perdomo I, Feres C, Prates MV, Paredes SR, Perez-Jacobo F, Ramirez-Ibarguen AF, Gajardo C, Roa Salinas MA, Otañez M, Valvert F, Arcuri LJ, Figueroa EM, Stefano MD, Baena R, Choque JA, Abello V, Valladares X, Sanchez S, Nancy C, Zambrano D, Lasso JF, Noboa A, Rojas C, Teixeira LL, Ospina JA, Torres Viera MA, Sotomayor E, Martinez H, Castillo JJ, Skarbnik A, Castillo LM. Updated Analysis Confirms Sustained Poor Prognosis of COVID-19 in Patients with Lymphoma in Latin America: A Cohort of 160 Patients from Gell. Blood 138(None):2520, 2021. PMID: None.
37. Malpica-Castillo L, Feng L, Xu J, Nair R, Elias A, Jain P, Chihara D, Steiner R, Fayad L, Samaniego F, Ahmed S, Fowler NH, Nastoupil L, Srour SA, Nieto Y, Hosing C, Miranda RN, Vega F, Pinnix CC, Gunther JR, Fang P, Wu S, Dabaja BS, Medeiros J, Wang M, Neelapu SS, Flowers CR, Iyer SP. Long Term Outcome Patterns and Risk Factors for Early Mortality and Disease Progression in ALK-Positive Anaplastic Large Cell Lymphoma. Blood 138(None):2463, 2021. PMID: None.
38. Villela L, Beltrán BE, Castro D, Ramirez-Ibarguen AF, Torres Viera MA, Perini GF, Lome C, Candelaria M, Idrobo H, Paredes SR, Glasenapp AV, Valvert F, Otero V, Peña C, Fiad L, Best C, Rios RO, Martinez-Cordero H, Otañez M, Pérez-Jacobo F, Idarraga JO, Baena R, Nancy C, Oliver AC, Irigoín MV, Cardoso LL, Rodriguez Y, Macias J, Prates MV, Luna MA, Cabrera ME, Roa M, Gajardo C, Díaz C, Montano Figueroa EH, Bichara E, Bonfil KL, Cordero-Moreno VL, Valcarcel B, Castillo JJ, Castillo LM. Biological and Classical Prognostic Factors with Impact on Overall Survival in Patients with Early Stage (I/II) Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL). None None(None):None, 2021. PMID: None.
39. Perini GF, Ospina Idarraga JA, Torres Viera MA, Beltran BE, Castro DA, Otero V, Kalmus M, Fiad L, Peña C, Idrobo H, Candelaria M, Glasenapp AV, Perdomo I, Feres C, Prates M, Paredes SR, Pérez-Jacobo F, Ramirez-Ibarguen A, Gajardo C, Roa Salinas MA, Cordero HM, Otañez M, Valvert F, Figueroa EM, Stefano MD, Baena R, Choque JA, Abello V, Valladares X, Sanchez S, Nancy C, Zambrano D, Lasso JF, Noboa A, Rojas C, Teixeira LL, Castillo LM, Sotomayor E, Castillo JJ, Villela LV. COVID-19 in Patients with Lymphoma: A Grupo De Estudio Latinoamericano En Linfoproliferativos (GELL) Retrospective Study. None 136(1):35-36, 2021. e-Pub 2020. PMID: None.
40. Vasquez Chavez JF, Zapata A, Garcia JL, Barrionuevo C, Diaz E, Poquioma E, Vidaurre T, Malpica AL. Incidence and Survival of Hodgkin Lymphoma Patients Treated at a National Cancer Center in a Middle-Income Country from 1999-2018: A Report of 1,382 cases. Journal of Clinical Oncology 39(15):None, 2021. PMID: None.
41. Marques-Piubelli ML, Solis LM, Malpica L, Gouni S, Nair R, Chihara D, Iyer SP, Wistuba II, Vega F, Strati P. Characterization of BCL-2 Alternative Proteins and Outcome in Patients with Peripheral T-cell Lymphoma (PTCL). Journal of Clinical Oncology 39(15):None, 2021. PMID: None.
42. Solf R, Aliaga R, Vallenas F, Flores CJ, Malpica L, Vasquez Chavez JF. Prognostic factors of Survival in Patients with Burkitt Lymphoma treated at the National Institute of Neoplastic Diseases in Peru: A 14 years’ experience. Journal of Clinical Oncology 39(15):None, 2021. PMID: None.
43. Vasquez Chavez JF, Diaz A, Enriquez D, Malpica L, Cabrejos M, Arias Castillo EA, Lopez LI, Quintana Truyenque SM, Flores CJ, Dueñas D, Barrionuevo C, Samanez CA. A comparative study of non-Hodgkin lymphoma between public versus private institution in a middle-income country: A report of 2,317 cases. Journal of Clinical Oncology 39(15):None, 2021. PMID: None.
44. Sandival-Ampuero G, Aviles-Perez U, Valcarcel B, Haro JC, Dueñas D, Barrionuevo C, Alcarraz C, Casavilca S, Villena M, Quintana S, Samanez-Figari C, Malpica Castillo LE, Enriquez DJ. Clinical Features and Outcome of HTLV-1 Carriers Diagnosed with Hodgkin Lymphoma in Peru: A Matched Cohort Study. Blood 136(1):22-23, 2020. PMID: None.
45. Villela LV, Ramirez-Ibarguen A, Beltran BE, Peña C, Castro DA, Agreda-Vasquez GP, Candelaria M, Torres Viera MA, Idrobo H, Fiad L, Valvert F, Figueroa EM, Idarraga JO, Glasenapp AV, Paredes S, Otañez M, Perez-Jacobo F, Zambrano D, Cordero HM, Otero V, Andino L, Arriola MR, Enciso ME, Prates M, Nancy C, Perdomo I, Cabrera ME, Cardozo ML, Frutos Ortiz CA, Riva E, Choque JA, Quiroz AR, Perini GF, Gomez-Almaguer D, Ruiz-Arguelles GJ, Distefano M, Garcia K, Feres C, Kalmus M, Cordova J, DelosRios M, Baena R, Castillo LM, Sotomayor E, Castillo JJ. Proposal of a Novel Latin American International Prognostic Index (LATAM-IPI) for Diffuse Large B-Cell Lymphoma (DLBCL) By the Grupo Para El Estudio De Linfoproliferativos En Latino-America (GELL). Blood 136(1):25-27, 2020. PMID: None.
46. Al-kassab-Córdova A, Lachira-Yparraguirre L, Sandival-Ampuero G, Roque K, Ortega E, Lozano-Ballena S, Haro JC, Quintana S, Villena M, Ferreyros-Brandon G, Garcia-Leon JL, Samanez-Figari C, Castillo LM, Enriquez D. Incidence and Outcome of Acute Myeloid Leukemia in Peru: An 11-Year Single Center Experience. None 136(1):28-29, 2020. PMID: None.
47. Valcarcel B, Enriquez DJ, Sandival-Ampuero G, Aviles-Perez U, Haro JC, Alcarraz C, Quintana S, Villena M, Dueñas D, Casavilca S, Barrionuevo C, Samanez-Figari C, Malpica Castillo LE. Clinical Characteristics and Outcome of Diffuse Large B Cell Lymphoma Among HTLV-1 Carriers in Peru: A Matched Cohort Study. Blood 136(1):38-39, 2020. PMID: None.
48. Malpica Castillo LE, Castro DA, Peña C, MD, Idrobo H, Enriquez DJ, Fiad L, Prates M, Otero V, Churin M, Altamirano M, Meza K, Moises C, Oviedo-Pecho R, Paredes A, Sanchez G, Aguirre-Martinez L, Valcarcel B, Nancy C, Maradei JL, Guanchiale L, Soto P, Viñuela JL, Cabrera ME, Aviles-Perez U, Sandival-Ampuero G, Paredes SR, Riva E, Stefano MD, Noboa A, Choque JA, Candelaria M, Glasenapp AV, Valvert F, Viera MT, Perini GF, Sotomayor E, Castillo JJ, Ramos JC, Villela LV, Beltran B. Impact of Cutaneous Involvement on the Clinical Outcome of Adult T-Cell Leukemia/Lymphoma: A Study from the Latin American Group of Lymphoproliferative Disorders (GELL). Blood 136(1):20-23, 2020. PMID: None.
49. Torres Viera MA, Beltran BE, Villela LV, Castro DA, Otero V, Fiad L, Peña C, Idrobo H, Candelaria M, Glasenapp AV, Perdomo I, Prates MV, Paredes SR, Pérez-Jacobo F, Ramirez-Ibarguen A, Ospina Idarraga JA, Cabrera ME, Gajardo C, Roa Salinas MA, Díaz C, Idárraga LS, Cordero HM, Otañez M, Valvert F, Figueroa EM, Stefano MD, Baena R, Choque JA, Abello V, Nancy C, Perini GF, Malpica Castillo LE, Sotomayor E, Castillo JJ. Follicular Lymphoma in Latin America: Real-World Experience from 763 Patients. Blood 136(1):12-13, 2020. PMID: None.
50. Malpica L, Mufuka B, Galeotti J, Tan X, Grover N, Clark SM, Beaven A, Muss H, Dittus C. A Retrospective Study on Prephase Therapy Prior to Definitive Multiagent Chemotherapy in Aggressive Lymphomas. Leukemia & lymphoma 6(61):1508–1511, 2020. PMID: None.
51. Torres Viera M, Beltrán B, Castro D, Villela L, Otero V, Fiad L, Peña C, Camara A, Otañez M, Idrobo H, Malpica L, Candelaria M, Ramirez A, Hernández-Hernández J, Montaño E, Pérez-Jacobo F, Best C, Castillo J. Pretreatment Serum Albumin Level is Associated with Higher Risk of POD24 in Latin American Patients With Follicular Lymphoma: A Study from The Latin American Group of Lymphoproliferatives (GELL). None None(None):None, 2020. PMID: None.
52. Malpica-Castillo LE, Palmer S, Zhu A, Deal AM, Chen SL, Moll S. Adherence to infectious disease screening and immunization guidelines when treating non-malignant immune-mediated hematologic disorders. Am J Hematol 95(3):E72-E75, 2020. e-Pub 2020. PMID: 31872481.
53. Idrobo H, Beltrán BE, Luis Villela M, Viera MT, Otero V, Fiad L, Peña C, Castro DA, Huerta- Collado YM, Paredes SR, Perdomo I, León P, Rojas C, Abello V, Pérez MO, Garcia-Robledo JE, Malpica Castillo LE, Sotomayor E, Castillo JJ. Serum Albumin Is an Independent Factor Predicting Survival in Patients with Peripheral T Cell Lymphoma: A Multi-Institutional Study from the Latin American Working Group for Lymphomas (GELL). Blood 134(1):4047, 2019. PMID: None.
54. Castro DA, Peña C, Rojas C, León P, Beltran BE, Huerta-Collado Y, Paredes S, Idrobo H, Perdomo I, Abello V, Fiad L, Otero V, Torres M, Villela L, Malpica L, Sotomayor EM, Castillo JJ. Lymphocyte Ratio in Patients with Diffuse Large B- Cell Lymphoma: A Study from the Latin American Working Group for Lymphomas (GELL). Blood 134(1):4121, 2019. PMID: None.
55. Villela L, Peña C, Rojas C, León P, Beltran BE, Castro DA, Huerta-Collado Y, Paredes S, Idrobo H, Perdomo I, Abello V, Fiad L, Otero V, Torres M, Malpica L, Sotomayor EM, Castillo JJ. Assessment of Different Biological Variables (Serum Albumin, β-2-Microglobulin, Lymphocyte/Monocyte ratio, Neutrophil/Lymphocyte ratio, Platelet/Lymphocyte ratio) in a Retrospective Cohort of 525 Diffuse Large B-Cell Lymphomas As Predictor Factor(s) for Overall Survival. None 134(1):1613, 2019. PMID: None.
56. Malpica Castillo LE, Peña C, Rojas C, León P, Beltrán BE, Castro DA, Huerta- Collado YM, Quinones M, Paredes SR, Idrobo H, Perdomo I, Abello V, Fiad L, Otero V, Viera MT, Luis Villela M, Sotomayor E, Castillo JJ, Ramos JC. Identifying a Simple Clinical Prognostic Model for Aggressive Adult T-Cell Leukemia/Lymphoma in Latin American Population and Its Validation: A Large International Study of the Latin America Working Group for Lymphomas (GELL). Blood 134(1):4045, 2019. PMID: None.
57. Malpica L, Leguia C, Freundt N, Barros N, Antunez de Mayolo A, White AC, Montes M. Increased Local Regulatory T cells and Diminished IgE Expression in Duodenal Mucosa of Strongyloides stercoralis/HTLV-1 Coinfected Patients. None 6(13):None, 2019. PMID: 31170141.
58. Malpica L, White AC, Leguia C, Freundt N, Barros N, Chian C, Antunez EA, Montes M. Regulatory T cells and IgE expression in duodenal mucosa of Strongyloides stercoralis and human T lymphotropic virus type 1 co-infected patients. PLoS Negl Trop Dis 13(6):e0007415, 2019. e-Pub 2019. PMID: 31170141.
59. Malpica L, Pimentel A, Reis IM, Gotuzzo E, Lekakis L, Komanduri K, Harrington T, Barber GN, C Ramos AJ. Epidemiology, Clinical Features, and Outcome of HTLV-1 Related Adult T-Cell Leukemia-Lymphoma in a Prevalent Area in the United States. Blood Adv 6(2):607-620, 2018. PMID: 29545256.
60. Malpica Castillo LE, MD, Campuzano-Zuluaga G, MD, Toomey NL, BS, Pimentel A, MD, Alencar AJ, MD, Chapman-Fredricks JR, MD, Ramos JC, MD BS. Targeting CD30 Expression in Adult T-Cell Leukemia-Lymphoma (ATLL). None 1(130):374, 2017. PMID: None.
61. Dawar R, Palacio S, Monge J, Torres A, Salzberg M, Castillo LE, Saravia D, Amarapurkar P, Hurley J. Chest imaging in patients with breast cancer treated with curative intent. Cancer Res 76(4):6–11–05, 2016. PMID: None.
62. R Dawar R, S Palacio S, Malpica Castillo LE, Hurley J. Chest imaging in patients with breast cancer treated with curative intent. Cancer Research 4(None):None, 2016. PMID: None.

Book Chapters

1. Malpica L, Aleman M. Cases of Hematology and Oncology. In: Spanish and the Medical Interview: Clinical Cases and Exam Review. None. None, 2020.
2. Malpica Castillo, LE, Dittus, C. Adult T-cell leukemia/lymphoma. In: Novel Therapeutics for Rare Lymphomas, 137-164, 2019.

Letters to the Editor

1. Marques-Piubelli, ML, Solis Soto, LM, Parra Cuentas, ER, Malpica Castillo, LE, Gouni, S, Nair, R, Chihara, D, Konopleva, M, Wistuba, II, Iyer, SP, Vega Vazquez, F, Strati, P. BCL-W expression associates with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified. Blood cancer journal 11, 2021.
2. Malpica Castillo LE, Palmer S, Zhu A, Deal AM, Chen SL, Moll S. Incidence and time course of neutropenia in patients treated with rituximab-based therapy for non-malignant immune-mediated hematologic diseases. Am J Hematol 95: E117-E120, 2020.